Related references
Note: Only part of the references are listed.Diabetes is an inflammatory disease: evidence from traditional Chinese medicines
W. Xie et al.
DIABETES OBESITY & METABOLISM (2011)
Berberine: a potential phytochemical with multispectrum therapeutic activities
Parameswara Rao Vuddanda et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Acute Lung Injury Review
Kenji Tsushima et al.
INTERNAL MEDICINE (2009)
Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer
Yunfang Liu et al.
EUROPEAN JOURNAL OF CANCER (2008)
Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine
Yifei Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Divergent roles of endothelial NF-κB in multiple organ injury and bacterial clearance in mouse models of sepsis
Xiaobing Ye et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Combination of simvastatin with berberine improves the lipid-lowering efficacy
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Efficacy of berberine in patients with type 2 diabetes mellitus
Jun Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
A protocol for isolation and culture of human umbilical vein endothelial cells
Bruno Baudin et al.
NATURE PROTOCOLS (2007)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Mode of binding of the cytotoxic alkaloid berberine with the double helix oligonucleotide D(AAGAATTCTT)2
S Mazzini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
The endothelium in sepsis: Source of and a target for inflammation
CE Hack et al.
CRITICAL CARE MEDICINE (2001)